{{distinguish|Thymidine monophosphate}}
{{drugbox
| Watchedfields = changed
| verifiedrevid = 470615131
| drug_name =
| IUPAC_name = 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine
| image = Trimethoprim.svg
| width = 240
| alt = Structural formula of trimethoprim
| image2 = Trimethoprim-from-hydrochloride-xtal-1984-3D-balls.png
| width2 = 250
| alt2 = Ball-and-stick model of the trimethoprim molecule

<!--Clinical data-->
| pronounce         = {{IPAc-en|t|r|aɪ|ˈ|m|ɛ|θ|ə|p|r|ɪ|m}}
| tradename         =Proloprim, Monotrim, Triprim, others
| Drugs.com = {{drugs.com|monograph|trimethoprim}}
| MedlinePlus = a684025
| licence_US = Trimethoprim
| pregnancy_AU = B3
| pregnancy_US = C
| legal_AU = S4
| legal_CA = Rx-only
| legal_UK = POM
| legal_US = Rx-only
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability = 90–100%
| protein_bound = 44%
| metabolism = [[hepatic]]
| elimination_half-life = 8-12 hours
| excretion = Urine (50–60%), faeces (4%)

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 738-70-5
| ATC_prefix = J01
| ATC_suffix = EA01
| ATC_supplemental = {{ATCvet|J51|EA01}}
| PubChem = 5578
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00440
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 5376
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = AN164J8Y0X
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00145
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 45924
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 22
| PDB_ligand = TOP

<!--Chemical data-->
| C=14 | H=18 | N=4 | O=3 
| molecular_weight = 290.32 g/mol
| smiles = Nc1nc(N)ncc1Cc(cc2OC)cc(OC)c2OC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C14H18N4O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H4,15,16,17,18)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = IEDVJHCEMCRBQM-UHFFFAOYSA-N
}}
<!-- Definition and uses -->
'''Trimethoprim''' ('''TMP''') is an [[antibiotic]] used mainly in the treatment of [[urinary tract infection|bladder infection]]s.<ref name=AHFS2015>{{cite web|title=Trimethoprim|url=http://www.drugs.com/monograph/trimethoprim.html|publisher=The American Society of Health-System Pharmacists|accessdate=Aug 1, 2015|deadurl=no|archiveurl=https://web.archive.org/web/20150924014936/http://www.drugs.com/monograph/trimethoprim.html|archivedate=2015-09-24|df=}}</ref> Other uses include for [[acute otitis media|middle ear infections]] and [[travelers' diarrhea]].<ref name=AHFS2015/> With [[Trimethoprim/sulfamethoxazole|sulfamethoxazole]] or [[dapsone]] it may be used for [[Pneumocystis pneumonia|''Pneumocystis'' pneumonia]] in people with [[HIV/AIDS]].<ref name=AHFS2015/><ref>{{cite journal|last1=Masur|first1=H|last2=Brooks|first2=JT|last3=Benson|first3=CA|last4=Holmes|first4=KK|last5=Pau|first5=AK|last6=Kaplan|first6=JE|last7=National Institutes of|first7=Health|last8=Centers for Disease Control and|first8=Prevention|last9=HIV Medicine Association of the Infectious Diseases Society of|first9=America|title=Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America.|journal=Clinical Infectious Diseases|date=May 2014|volume=58|issue=9|pages=1308–11|pmid=24585567|doi=10.1093/cid/ciu094|pmc=3982842}}</ref> It is taken by mouth.<ref name=AHFS2015/>

<!-- Side effects -->
Common side effects include nausea, changes in taste, and rash.<ref name=AHFS2015/> Rarely it may result in blood problems such as not enough [[platelets]] or [[white blood cells]].<ref name=AHFS2015/> May cause sun sensitivity.<ref name=AHFS2015/> There is evidence of potential harm during [[pregnancy]] in some animals but not humans.<ref name=TGA2014>{{cite web|title=Prescribing medicines in pregnancy database|url=http://www.tga.gov.au/hp/medicines-pregnancy.htm#.U1Yw8Bc3tqw|work=Australian Government|accessdate=22 April 2014|date=3 March 2014|deadurl=no|archiveurl=https://web.archive.org/web/20140408040902/http://www.tga.gov.au/hp/medicines-pregnancy.htm#.U1Yw8Bc3tqw|archivedate=8 April 2014|df=}}</ref> It works by blocking [[folate]] metabolism via [[dihydrofolate reductase]] in some bacteria which results in their death.<ref name=AHFS2015/>

<!-- History, society and culture --> 
Trimethoprim was first used in 1962.<ref name=Huo2001>{{cite journal|last1=Huovinen|first1=P|title=Resistance to trimethoprim-sulfamethoxazole.|journal=Clinical Infectious Diseases|date=1 June 2001|volume=32|issue=11|pages=1608–14|pmid=11340533|doi=10.1086/320532}}</ref> It is on the [[World Health Organization's List of Essential Medicines]], the most effective and safe medicines needed in a [[health system]].<ref name=WHO19th>{{cite web|title=WHO Model List of Essential Medicines (19th List)|url=http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|work=World Health Organization|accessdate=8 December 2016|date=April 2015|deadurl=no|archiveurl=https://web.archive.org/web/20161213052708/http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|archivedate=13 December 2016|df=}}</ref> It is available as a generic medication and is not very expensive.<ref name=Ric2015>{{cite book|last1=Hamilton|first1=Richart|title=Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition|date=2015|publisher=Jones & Bartlett Learning|isbn=9781284057560|page=113}}</ref> In the United States 10 days of treatment is about 21 USD.<ref name=AHFS2015/>

==Medical uses==
It is primarily used in the treatment of [[urinary tract infections]], although it may be used against any susceptible [[Aerobic organism|aerobic bacterial species]].<ref name="AMH">{{cite book | editor = Rossi, S | isbn = 978-0-9805790-9-3 | title = Australian Medicines Handbook | place = Adelaide | publisher = The Australian Medicines Handbook Unit Trust | year = 2013 | edition = 2013 }}</ref> It may also be used to treat and prevent ''[[Pneumocystis jiroveci]]'' pneumonia.<ref name = AMH/> It is generally not recommended for the treatment of [[Anaerobic organism|anaerobic infections]] such as [[Clostridium difficile colitis|''Clostridium difficile'' colitis]] (the leading cause of antibiotic-induced diarrhea).<ref name = AMH/> Trimethoprim has been used in trials to treat [[toxoplasmic chorioretinitis|retinitis]].<ref name="Pradhan">{{cite journal |author= Pradhan E, Bhandari S, Gilbert RE, Stanford M |title= Antibiotics versus no treatment for toxoplasma retinochoroiditis |journal=Cochrane Database Syst Rev|volume=5 |pages= CD002218 |date=2016 |pmid= 27198629 |doi= 10.1002/14651858.CD002218.pub2}}</ref>

Resistance to trimethoprim is increasing, but it is still a first line antibiotic in many countries.<ref>{{cite web |url=https://www.nice.org.uk/advice/ktt10/chapter/evidence-context |title=Archived copy |accessdate=2015-12-30 |deadurl=no |archiveurl=https://web.archive.org/web/20151208004951/http://www.nice.org.uk/advice/ktt10/chapter/Evidence-context |archivedate=2015-12-08 |df= }}</ref>

===Spectrum of susceptibility===
Cultures and susceptibility tests should be done to make sure bacteria is treated by trimethoprim.<ref name="dailymed.nlm.nih.gov">{{Cite web|title = DailyMed - TRIMETHOPRIM- trimethoprim tablet|url = http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a4e9183f-d0eb-4ba7-9204-760b1fd62010|website = dailymed.nlm.nih.gov|accessdate = 2015-11-04|deadurl = no|archiveurl = https://web.archive.org/web/20150930162821/http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a4e9183f-d0eb-4ba7-9204-760b1fd62010|archivedate = 2015-09-30|df = }}</ref><ref>{{Cite web|title = DailyMed - PRIMSOL- trimethoprim hydrochloride solution|url = http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a06ea7d8-a884-4b62-a87f-c36d824f2aa4|website = dailymed.nlm.nih.gov|accessdate = 2015-11-04|deadurl = no|archiveurl = https://web.archive.org/web/20151117024132/https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a06ea7d8-a884-4b62-a87f-c36d824f2aa4|archivedate = 2015-11-17|df = }}</ref>
* ''[[Escherichia coli]]''
* ''[[Proteus mirabilis]]''
* ''[[Klebsiella pneumoniae]]''
* ''[[Enterobacter]]'' species
* [[Coagulase|Coagulase-negative]] ''[[Staphylococcus]]'' species, including [[Staphylococcus saprophyticus|''S. saprophyticus'']]
* ''[[Streptococcus pneumoniae]]''
* ''[[Haemophilus influenzae]]''

==Side effects==

=== Common  ===
* Nausea
* Change in taste
* Vomiting 
* Diarrhea 
* Rash 
* Sun sensitivity 
* Itchiness<ref name=":1">{{Cite web|title = PROLOPRIM® (trimethoprim)100-mg and 200-mg Scored Tablets|url = http://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=3220|website = dailymed.nlm.nih.gov|accessdate = 2015-11-04|deadurl = no|archiveurl = https://web.archive.org/web/20151117015344/http://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=3220|archivedate = 2015-11-17|df = }}</ref><ref>{{Cite book|title = American Hospital Formulary Service- Drug Information 2002.|last = Ellenhorn, M.J. |author2 = S. Schonwald |author3 = G. Ordog |author4 = J. Wasserberger |publisher = Williams and Wilkins|location = Baltimore, MD|pages = 236}}</ref>

=== Rare ===
* Can cause [[thrombocytopenia]] (low levels of [[platelets]]) by lowering [[folic acid]] levels; this may also cause [[megaloblastic anemia]].<ref name=":2">{{Cite book|title = Drug Information for the Health Care Professional. 22nd ed. Volume 1.|last = MICROMEDEX Thomson Health Care. USPDIpublisher = Thomson Health |location = CareGreenwood Village, CO. 2002 p. 2849}}</ref>
* Trimethoprim antagonizes the [[epithelial sodium channel]] <!-- (ENaC) --> in the [[distal tubule]], thus acting like [[amiloride]].  This can cause increased potassium levels in the body ([[hyperkalemia]]).<ref>{{Cite journal|title = Trimethoprim-Induced Hyperkalemia in a Patient with AIDS|url = http://dx.doi.org/10.1056/NEJM199303113281006|journal = New England Journal of Medicine|date = 1993-03-11|issn = 0028-4793|pmid = 8433730|pages = 703–706|volume = 328|issue = 10|doi = 10.1056/NEJM199303113281006|first = Michael J.|last = Choi|first2 = Pedro C.|last2 = Fernandez|first3 = Asit|last3 = Patnaik|first4 = Brigitte|last4 = Coupaye-Gerard|first5 = Denise|last5 = D'Andrea|first6 = Harold|last6 = Szerlip|first7 = Thomas R.|last7 = Kleyman}}</ref> 
* Can compete with [[creatinine]] for secretion into the renal tubule.  This can cause an artificial rise in the serum creatinine.<ref>{{Cite journal|title = Effects of moderate-dose versus high-dose trimethoprim on serum creatinine and creatinine clearance and adverse reactions|journal = Antimicrobial Agents and Chemotherapy|date = 1997-11-01|issn = 0066-4804|pmc = 164146|pmid = 9371351|pages = 2466–2470|volume = 41|issue = 11|first = O.|last = Naderer|first2 = A. N.|last2 = Nafziger|first3 = J. S.|last3 = Bertino}}</ref> 
* Use in [[EHEC]] infections may lead to an increase in expression of [[Shiga toxin]].<ref>{{cite journal | vauthors = Kimmitt PT, Harwood CR, Barer MR | title = Toxin Gene Expression by Shiga Toxin-producing ''Escherichia coli'': The Role of Antibiotics and the Bacterial SOS Response | journal = Emerg Infect Dis | year = 2000 | volume = 6 | issue = 5 | pages = 458–465 | pmid = 10998375 | pmc = 2627954 | url = http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2627954/pdf/10998375.pdf | format = pdf | doi = 10.3201/eid0605.000503 | deadurl = no | archiveurl = https://web.archive.org/web/20170908145813/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2627954/pdf/10998375.pdf | archivedate = 2017-09-08 | df =  }}</ref>

=== Contraindications ===
* Known [[hypersensitivity]] to trimethoprim
* History of [[megaloblastic anemia]] due to folate deficiency<ref name=":0">{{Cite web|title = DailyMed - PRIMSOL- trimethoprim hydrochloride solution|url = https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a06ea7d8-a884-4b62-a87f-c36d824f2aa4|website = dailymed.nlm.nih.gov|accessdate = 2015-11-04|deadurl = no|archiveurl = https://web.archive.org/web/20151117024132/https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a06ea7d8-a884-4b62-a87f-c36d824f2aa4|archivedate = 2015-11-17|df = }}</ref><!-- supports all -->

=== Liver and kidney problems ===
10-20% of trimethoprim is metabolized by the liver and the rest is excreted in the urine. Therefore, trimethoprim should be used with caution in individuals with kidney and liver impairments. Dosage adjustment is not needed for liver impairment but should be adjusted for kidney impairment.<ref>{{Cite web|title = DailyMed - TRIMETHOPRIM- trimethoprim tablet|url = http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a4e9183f-d0eb-4ba7-9204-760b1fd62010#AC6312A3-129B-49F2-99C3-E1C96A3B1A6E|website = dailymed.nlm.nih.gov|accessdate = 2015-11-04|deadurl = no|archiveurl = https://web.archive.org/web/20150930162821/http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a4e9183f-d0eb-4ba7-9204-760b1fd62010#AC6312A3-129B-49F2-99C3-E1C96A3B1A6E|archivedate = 2015-09-30|df = }}</ref>

=== Pregnancy ===
Based on studies that show that trimethoprim crosses the [[placenta]] and can affect folate metabolism, there has been growing evidence of the risk of structural birth defects associated with trimethoprim, especially during the first [[Pregnancy|trimester]] of pregnancy.<ref name="Sivojelezova 1085–1086">{{Cite journal|title = Trimethoprim-sulfonamide combination therapy in early pregnancy.|journal = Canadian Family Physician|date = 2003-09-01|issn = 0008-350X|pmc = 2214286|pmid = 14526858|pages = 1085–1086|volume = 49|first = Anna|last = Sivojelezova|first2 = Adrienne|last2 = Einarson|first3 = Samar|last3 = Shuhaiber|first4 = Gideon|last4 = Koren}}</ref> It may be involved in a reaction similar to [[disulfiram]] when alcohol is consumed after it is used, in particular when used in combination with [[sulfamethoxazole]].<ref>{{cite journal | vauthors = Edwards DL, Fink PC, van Dyke PO | title = Disulfiram-like reaction associated with intravenous trimethoprim-sulfamethoxazole and metronidazole | journal = J Clinical pharmacy | year = 1986 | volume = 5 | issue = 12 | pages = 999–1000 | pmid = 3492326 | url = http://cat.inist.fr/?aModele=afficheN&cpsidt=8287529 | deadurl = no | archiveurl = https://web.archive.org/web/20090124113327/http://cat.inist.fr/?aModele=afficheN&cpsidt=8287529 | archivedate = 2009-01-24 | df =  }}</ref><ref>{{cite journal | vauthors = Heelon MW, White M | title = Disulfiram cotrimoxazole reaction | journal = J Pharmacotherapy | year = 1998 | volume = 18 | issue = 4 | pages = 869–870 | pmid = 9692665 | url = http://cat.inist.fr/?aModele=afficheN&cpsidt=2340043 | deadurl = no | archiveurl = https://web.archive.org/web/20090124113456/http://cat.inist.fr/?aModele=afficheN&cpsidt=2340043 | archivedate = 2009-01-24 | df =  }}</ref>
The trophoblasts in the early fetus are sensitive to changes in the folate cycle. A recent study has found a doubling in the risk of miscarriage in women exposed to trimethoprim in the early pregnancy.<ref>{{cite journal | vauthors = Andersen JT, Petersen M, Jimenez-Solem E, Broedbaek K, Andersen EW, Andersen NL, Afzal S, Torp-Pedersen C, Keiding N, Poulsen HE | title = Trimethoprim use in early pregnancy and the risk of miscarriage: a register-based nationwide cohort study | journal = Epidemiology and Infection | year = 2013 | volume = 141 | issue = 8 | pages = 1749–1755 | doi = 10.1017/S0950268812002178 | pmid = 23010291 | url = http://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=8953186 | deadurl = no | archiveurl = https://web.archive.org/web/20130929103010/http://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=8953186 | archivedate = 2013-09-29 | df =  }}</ref>

==Mechanism of action==
[[Image:THFsynthesispathway.png|[[Tetrahydrofolate]] synthesis pathway|thumb]]
[[File:Wild-type staphylococcus aureus DHFR in complex with NADPH and trimethoprim.gif|thumb|''Staphylococcus aureus'' DHFR in complex with NADPH and trimethoprim PDB entry {{PDBe|2W9G}} <ref>{{Cite journal  | last1 = Heaslet | first1 = H.  | last2 = Harris | first2 = M.  | last3 = Fahnoe | first3 = K.  | last4 = Sarver | first4 = R.  | last5 = Putz | first5 = H.  | last6 = Chang | first6 = J.  | last7 = Subramanyam | first7 = C.  | last8 = Barreiro | first8 = G.  | last9 = Miller | first9 = J. R.  | doi = 10.1002/prot.22383  | title = Structural comparison of chromosomal and exogenous dihydrofolate reductase fromStaphylococcus aureusin complex with the potent inhibitor trimethoprim  | journal = Proteins: Structure, Function, and Bioinformatics  | volume = 76  | issue = 3  | pages = 706–717  | year = 2009  | pmid = 19280600  | pmc =  }}</ref>]]
Trimethoprim binds to [[dihydrofolate reductase]] and inhibits the reduction of [[dihydrofolic acid]] (DHF) to [[tetrahydrofolic acid]] (THF).<ref name = drugs82/> THF is an essential precursor in the thymidine synthesis pathway and interference with this pathway inhibits bacterial DNA synthesis.<ref name = drugs82/> Trimethoprim's affinity for bacterial dihydrofolate reductase is several thousand times greater than its affinity for human dihydrofolate reductase.<ref name = drugs82/> [[Sulfamethoxazole]] inhibits [[dihydropteroate synthase]], an enzyme involved further upstream in the same pathway.<ref name = drugs82/> [[Trimethoprim/sulfamethoxazole|Trimethoprim and sulfamethoxazole]] are commonly used in combination due to possible synergistic effects, and reduced development of resistance.<ref name = drugs82>{{cite journal|last=Brogden|first=RN|author2=Carmine, AA |author3=Heel, RC |author4=Speight, TM |author5= Avery, GS |title=Trimethoprim: a review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections.|journal=Drugs|date=June 1982|volume=23|issue=6|pages=405–30|doi=10.2165/00003495-198223060-00001|pmid=7049657}}</ref> This benefit has been questioned.<ref name=Brumfitt1993>{{cite journal |author1=Brumfitt, W |author2=Hamilton-Miller, JM |title=Reassessment of the rationale for the combinations of sulphonamides with diaminopyrimidines | journal=Journal of Chemotherapy |date=December 1993|volume=5|issue=6|pages=465–9|pmid=8195839}}</ref>{{stack end}}

==History==
Trimethoprim was first used in 1962.<ref name=Huo2001/> In 1972, it was used as a prophylactic treatment for urinary tract infections in Finland.<ref name="Huo2001"/>

==See also==
*[[Tetroxoprim]]
*[[Iclaprim]]
{{Clear}}

== References ==
{{reflist|2}}

==External links==
* [http://www.med.sc.edu:96/Biopharm/PDFs/NucleicAcidInhibitors.pdf Nucleic acid inhibitors] (PDF file).

{{Sulfonamides and trimethoprim}}

[[Category:Antibiotics]]
[[Category:Bacterial dihydrofolate reductase inhibitors]]
[[Category:Protozoal dihydrofolate reductase inhibitors]]
[[Category:Pyrimidines]]
[[Category:World Health Organization essential medicines]]
[[Category:Phenol ethers]]
[[Category:Aromatic amines]]
[[Category:RTT]]
[[Category:Antimetabolites]]